UPDATE 2-GSK cancer vaccine disappoints in melanoma trial

An experimental cancer vaccine from GlaxoSmithKline failed to help melanoma patients in a closely watched late-stage clinical trial, dealing a blow to the high-risk, high-reward project.

http://www.reuters.com/article/2013/09/05/glaxosmithkline-melanoma-idUSL6N0H10FU20130905?feedType=RSS&feedName=marketsNews